Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
p32 regulates mitochondrial morphology and dynamics through parkin.
Li Y, Wan OW, Xie W, Chung KK.
Neuroscience. 2011 Dec 29;199:346-58. Epub 2011 Oct 10.
Related citations
The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability.
Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Fantaneanu T, Paulson HL, Fon EA.
Hum Mol Genet. 2011 Jan 1;20(1):141-54. Epub 2010 Oct 11.
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.
Ko HS, Lee Y, Shin JH, Karuppagounder SS, Gadad BS, Koleske AJ, Pletnikova O, Troncoso JC, Dawson VL, Dawson TM.
Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16691-6. Epub 2010 Sep 7.
Parkin is ubiquitinated by Nrdp1 and abrogates Nrdp1-induced oxidative stress.
Yu F, Zhou J.
Neurosci Lett. 2008 Jul 25;440(1):4-8. Epub 2008 May 18.
alpha-Synuclein aggregates interfere with Parkin solubility and distribution: role in the pathogenesis of Parkinson disease.
Kawahara K, Hashimoto M, Bar-On P, Ho GJ, Crews L, Mizuno H, Rockenstein E, Imam SZ, Masliah E.
J Biol Chem. 2008 Mar 14;283(11):6979-87. Epub 2008 Jan 14.
Parkin interacts with LIM Kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination.
Lim MK, Kawamura T, Ohsawa Y, Ohtsubo M, Asakawa S, Takayanagi A, Shimizu N.
Exp Cell Res. 2007 Aug 1;313(13):2858-74. Epub 2007 Apr 20.
Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation.
Avraham E, Rott R, Liani E, Szargel R, Engelender S.
J Biol Chem. 2007 Apr 27;282(17):12842-50. Epub 2007 Feb 27.
Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
Hampe C, Ardila-Osorio H, Fournier M, Brice A, Corti O.
Hum Mol Genet. 2006 Jul 1;15(13):2059-75. Epub 2006 May 19.
Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.
Smith WW, Pei Z, Jiang H, Moore DJ, Liang Y, West AB, Dawson VL, Dawson TM, Ross CA.
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18676-81. Epub 2005 Dec 13.
Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
Sriram SR, Li X, Ko HS, Chung KK, Wong E, Lim KL, Dawson VL, Dawson TM.
Hum Mol Genet. 2005 Sep 1;14(17):2571-86. Epub 2005 Jul 27.
Physical and functional interaction between Dorfin and Valosin-containing protein that are colocalized in ubiquitylated inclusions in neurodegenerative disorders.
Ishigaki S, Hishikawa N, Niwa J, Iemura S, Natsume T, Hori S, Kakizuka A, Tanaka K, Sobue G.
J Biol Chem. 2004 Dec 3;279(49):51376-85. Epub 2004 Sep 29.
Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity.
Imai Y, Soda M, Takahashi R.
J Biol Chem. 2000 Nov 17;275(46):35661-4.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on